Governments may have to reserve 20% of vaccines: WHO

Draft WHO agreement aims at more robust and fairer response to future pandemics | 20% of tests and drugs would go to the organisation, including 10% donated.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Vaccine makers hit back against patent claims

28 July 2022 German biotech and its US big pharma partner file counter complaint | Under-fire pair say they didn’t infringe patents | Claims reject earlier suit as an attempt to profit through legal threats.

article

WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?

23 June 2022 The COVID-19 IP agreement promises to enable developing countries more autonomy to produce and distribute vaccines, but it has attracted many critics, finds Sarah Speight.

More features

AIPPI: Personalised medicine tests the limits in patent law

Ropes & Gray loses 21-attorney group to join rival on growth spree

How 'Boehringer' sets preliminary relief threshold for generics

‘Whose trademark law is AI based on exactly?’: Key questions from Marques

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Governments may have to reserve 20% of vaccines: WHO

More on this story

Editor's picks

Editor's picks

More features